Managing Contrast-Induced Nephropathy in Patients with Renal Impairment

Risk Assessment

A GFR of 36 mL/min/1.73m² represents moderate renal impairment and is a significant risk factor for contrast-induced nephropathy (CIN) 1, 2
Pre-existing impairment in renal function is the principal risk factor for contrast-induced acute kidney injury 1

Fluid volume loading is the single most important preventive measure for patients with GFR <60 mL/min 1
Adequate preprocedural hydration should be implemented for all patients with GFR <45 mL/min receiving intravenous contrast 1
Use low-osmolar or iso-osmolar contrast agents 1
Nonionic low-osmolar contrast material is recommended as it may be associated with lower incidence of contrast-induced nephropathy 3

Medications such as NSAIDs should be considered for holding before contrast administration 4
Metformin should be withheld at the time of procedure and for 48 hours after 4
Aminoglycosides should be discontinued before contrast administration 1

Monitor for signs of acute kidney injury, which is typically defined as an increase in serum creatinine of ≥0.5 mg/dL or ≥25-50% from baseline within 2-5 days following contrast administration 1

The American College of Radiology recommends weighing the benefit of diagnostic information from the contrast-enhanced CT against the potential risk of CIN 2, 5
For patients with GFR between 30-60 mL/min/1.73m², proceeding with contrast is justified if the clinical question cannot be answered with an alternative imaging modality and the information is critical for patient management 2, 5

The patient with GFR of 36 mL/min/1.73m² falls into a moderate risk category 2
Additional risk factors that would increase concern include diabetes mellitus, heart failure, recent contrast exposure, and advanced age (>70 years) 1, 4

Hydration with isotonic saline before administration of contrast medium is strongly recommended (Class I, Level A recommendation) in patients with stage 3a CKD (GFR 45-59 ml/min/1.73m²) 6
Use low-osmolar or iso-osmolar contrast media (Class I, Level A recommendation) is advised for patients with stage 3a CKD (GFR 45-59 ml/min/1.73m²) 7, 6
Minimize the volume of contrast media (Class I, Level B recommendation) to reduce the risk of contrast-induced nephropathy in stage 3a CKD patients 7
Consider short-term high-dose statin therapy before the procedure (Class IIa, Level A recommendation) for patients with stage 3a CKD (GFR 45-59 ml/min/1.73m²) 6

The American College of Radiology recommends proceeding with contrast if the clinical question cannot be answered with an alternative imaging modality and the information is critical for patient management in patients with stage 3a CKD 8
When angiography is clinically needed, the risk of contrast-induced AKI should not be a reason to forego the procedure in most patients with CKD, according to the American Journal of Kidney Diseases 9

Patients with serum creatinine >2 mg/dL have a 22.4% risk of contrast-induced AKI (CI-AKI) compared to 2.4% in those with normal renal function, according to the American Journal of Kidney Diseases 10

Proceed immediately with contrast if life-threatening conditions requiring urgent diagnosis are present, such as ST-elevation MI, aortic dissection, or pulmonary embolism, as recommended by the American Journal of Kidney Diseases 10
Consider delaying the procedure if the clinical question can be answered with non-contrast CT, MRI without gadolinium, or ultrasound, as suggested by the American Journal of Kidney Diseases 11, 12

Administer isotonic sodium chloride (0.9% normal saline) or sodium bicarbonate at 1 mL/kg/hour starting 12 hours before and continuing 24 hours after the procedure, as recommended by the American Journal of Kidney Diseases with Level 1A evidence 11, 12
Use iso-osmolar (iodixanol) or low-osmolar contrast media only, as recommended by the American Journal of Kidney Diseases with Level 1B evidence 11, 12, 10
Use the absolute minimum volume of contrast necessary for diagnostic quality, as recommended by the American Journal of Kidney Diseases 11, 12

Do not use prophylactic hemodialysis or hemofiltration for contrast removal, as recommended against by the American Journal of Kidney Diseases with Level 2C evidence 11, 12
Do not rely on oral hydration alone in high-risk patients, as recommended against by the American Journal of Kidney Diseases 11, 12
Do not delay urgent life-saving procedures due to fear of CI-AKI, as recommended by the American Journal of Kidney Diseases 10

Monitor serum creatinine at 48-72 hours post-procedure, and watch for volume overload, severe electrolyte disturbances, or uremic symptoms that may require dialysis, as recommended by the American Journal of Kidney Diseases 13